Announcements Trials

Browse Landscape

Phase

Phase 2 24 Phase 3 16 Phase 1 4 Phase NA 2 Phase 1/2 2 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 1

Interventions

Cisplatin 30 Magnetic Resonance Spectroscopy 23 Carboplatin 23 pembrolizumab 21 Paclitaxel 20 Gemcitabine 19 Specimen Handling 16 Dexamethasone 15 Radiotherapy 14 Nivolumab 14 Drug Therapy 14 Doxorubicin 14 Bevacizumab 14 atezolizumab 13 Oxaliplatin 13 Cyclophosphamide 13 Radiation 11 Pemetrexed 11 Cytarabine 11 venetoclax 10 Vincristine 10 Prednisone 10 Docetaxel 10 Capecitabine 10 Trastuzumab 9 Temozolomide 8 Rituximab 8 Platinum 8 Ipilimumab 8 Fluorouracil 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Gonadotropin-Releasing Hormone × 1 year × Clear all

NCT07319429 2026-03-13

FEMUS

Fudan University

Phase 2/3 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡